Özge Saatci

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Özge Saatci, Aysegül Kaymak, Umar Raza et al. · Nature Communications · 2020 · 364 citations · Full text

Medicine, Cancer Biology, Oncology +17

Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells

Annemarie Schwab, Aarif Siddiqui, Maria Eleni Vazakidou et al. · Cancer Research · 2018 · 132 citations · Full text

Medicine, Molecular Biology, Oncology +17

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer

Özge Saatci, Simone Borgoni, Özge Akbulut et al. · Oncogene · 2018 · 81 citations · Full text

Medicine, Cell Biology, Oncology +15

miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer

Merve Mutlu, Özge Saatci, Suhail A. Ansari et al. · Scientific Reports · 2016 · 74 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer

Rasmi R. Mishra, Nevin Belder, Suhail A. Ansari et al. · Clinical Cancer Research · 2018 · 66 citations · Full text

Medicine, Oncology, Pharmacology +16